The default category

Imagine Eyes' business operations during covid-19

Dear Customers and Partners, All of us at Imagine Eyes deeply sympathize with the people impacted by covid-19 worldwide.…

Imagine Eyes’ AO retinal imaging system receives regulatory clearance in China

March 09, 2020, Orsay, France, and Beijing, China. Imagine Eyes' flagship product, the rtx1-e Adaptive Optics retinal camera,…

Retinal artery walls analyzed with AO imaging in a large cohort

The Copenhagen Child Cohort 2000 Study used adaptive optics imaging to assess small artery walls in the retinas of over…

First rtx1 findings in endocrinology got published

"... a new tool for cardiovascular risk assessment and treatment follow-up in acromegaly patients" A study recently published…

Christophe Rondeau appointed as R&D Engineer

Christophe Rondeau recently joined Imagine Eyes’ team as an R&D Engineer. “We are happy to welcome Christophe and,…

Already 168 rtx1 publications listed in our public library

The rtx1 Adaptive Optics Retinal Camera has enabled examining cellular and microvascular detail at the back of the eye. Clinical…

rtx1 study quantifies photoreceptor cell loss in Retinitis Pigmentosa patients

Ophthalmologists at Wenzhou Medical University Eye Hospital in China have used Imagine Eyes' rtx1 adaptive optics retinal…

New: Follow-up module for the rtx1 AO retinal camera

A new software version – AOimage 3.4 – is now available for the rtx1 Adaptive Optics retinal camera. It enables tracking…

10 years of adaptive optics retinal imaging

On the occasion of the "10 years of vision research" celebration of Institut de la Vision, Prof. Kiyoko Gocho (Nippon Medical…

Presentation at the Ophthalmic Imaging Symposium in Rotterdam

Imagine Eye's CEO, Nicolas Chateau, will speak at the CORR Ophthalmic Imaging Symposium, in Rotterdam on October 4th, 2019.…